112 related articles for article (PubMed ID: 10327383)
1. Oral phentolamine and female sexual arousal disorder: a pilot study.
Rosen RC; Phillips NA; Gendrano NC; Ferguson DM
J Sex Marital Ther; 1999; 25(2):137-44. PubMed ID: 10327383
[TBL] [Abstract][Full Text] [Related]
2. Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study.
Rubio-Aurioles E; Lopez M; Lipezker M; Lara C; Ramírez A; Rampazzo C; Hurtado de Mendoza MT; Lowrey F; Loehr LA; Lammers P
J Sex Marital Ther; 2002; 28 Suppl 1():205-15. PubMed ID: 11898704
[TBL] [Abstract][Full Text] [Related]
3. Topical alprostadil in the treatment of Female Sexual Arousal Disorder: a pilot study.
Islam A; Mitchel J; Rosen R; Phillips N; Ayers C; Ferguson D; Yeager J
J Sex Marital Ther; 2001; 27(5):531-40. PubMed ID: 11554216
[TBL] [Abstract][Full Text] [Related]
4. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: a randomised controlled trial.
Basson R; Brotto LA
BJOG; 2003 Nov; 110(11):1014-24. PubMed ID: 14592587
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
Labrie F; Archer D; Bouchard C; Fortier M; Cusan L; Gomez JL; Girard G; Baron M; Ayotte N; Moreau M; Dubé R; Côté I; Labrie C; Lavoie L; Berger L; Gilbert L; Martel C; Balser J
Menopause; 2009; 16(5):923-31. PubMed ID: 19424093
[TBL] [Abstract][Full Text] [Related]
6. Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder.
Caruso S; Agnello C; Intelisano G; Farina M; Di Mari L; Cianci A
Urology; 2004 May; 63(5):955-9. PubMed ID: 15134988
[TBL] [Abstract][Full Text] [Related]
7. Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder.
Ferguson DM; Steidle CP; Singh GS; Alexander JS; Weihmiller MK; Crosby MG
J Sex Marital Ther; 2003; 29 Suppl 1():33-44. PubMed ID: 12735087
[TBL] [Abstract][Full Text] [Related]
8. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women.
Laan E; van Lunsen RH; Everaerd W
Climacteric; 2001 Mar; 4(1):28-41. PubMed ID: 11379375
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topical alprostadil cream for the treatment of female sexual arousal disorder (FSAD): a double-blind, multicenter, randomized, and placebo-controlled clinical trial.
Padma-Nathan H; Brown C; Fendl J; Salem S; Yeager J; Harningr R
J Sex Marital Ther; 2003; 29(5):329-44. PubMed ID: 14504005
[TBL] [Abstract][Full Text] [Related]
10. Effects of experimentally adopted sexual schemas on vaginal response and subjective sexual arousal: a comparison between women with sexual arousal disorder and sexually healthy women.
Middleton LS; Kuffel SW; Heiman JR
Arch Sex Behav; 2008 Dec; 37(6):950-61. PubMed ID: 18256919
[TBL] [Abstract][Full Text] [Related]
11. Pharmacotherapy for women's sexual dysfunction.
Basson R
Expert Opin Pharmacother; 2009 Jul; 10(10):1631-48. PubMed ID: 19527189
[TBL] [Abstract][Full Text] [Related]
12. Topical alprostadil treatment of female sexual arousal disorder.
Kielbasa LA; Daniel KL
Ann Pharmacother; 2006; 40(7-8):1369-76. PubMed ID: 16757679
[TBL] [Abstract][Full Text] [Related]
13. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
[TBL] [Abstract][Full Text] [Related]
14. A psychoeducational intervention for sexual dysfunction in women with gynecologic cancer.
Brotto LA; Heiman JR; Goff B; Greer B; Lentz GM; Swisher E; Tamimi H; Van Blaricom A
Arch Sex Behav; 2008 Apr; 37(2):317-29. PubMed ID: 17680353
[TBL] [Abstract][Full Text] [Related]
15. [Female sexual dysfunction: a systematic overview of classification, pathophysiology, diagnosis and treatment].
Marthol H; Hilz MJ
Fortschr Neurol Psychiatr; 2004 Mar; 72(3):121-35. PubMed ID: 14999592
[TBL] [Abstract][Full Text] [Related]
16. Laboratory-induced hyperventilation differentiates female sexual arousal disorder subtypes.
Brotto LA; Klein C; Gorzalka BB
Arch Sex Behav; 2009 Aug; 38(4):463-75. PubMed ID: 18343989
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of alprostadil cream for the treatment of female sexual arousal disorder: a double-blind, placebo-controlled study in chinese population.
Liao Q; Zhang M; Geng L; Wang X; Song X; Xia P; Lu T; Lu M; Liu V
J Sex Med; 2008 Aug; 5(8):1923-31. PubMed ID: 18564348
[TBL] [Abstract][Full Text] [Related]
19. Effects of Korean red ginseng on sexual arousal in menopausal women: placebo-controlled, double-blind crossover clinical study.
Oh KJ; Chae MJ; Lee HS; Hong HD; Park K
J Sex Med; 2010 Apr; 7(4 Pt 1):1469-77. PubMed ID: 20141583
[TBL] [Abstract][Full Text] [Related]
20. Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women.
Heard-Davison A; Heiman JR; Kuffel S
J Sex Med; 2007 Jan; 4(1):209-217. PubMed ID: 17233787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
